HNB
GMAB icon

Huntington National Bank’s Genmab GMAB Stock Holding History

Huntington National Bank’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Buy
377
+35
+10% +$930 ﹤0.01% 2011
2026
Q1 		$9.18K Sell
342
-18
-5% -$539 ﹤0.01% 1890
2025
Q4 		$11.1K Sell
360
-256
-42% -$7.98K ﹤0.01% 1762
2025
Q3 		$18.9K Buy
616
+53
+9% +$1.29K ﹤0.01% 1615
2025
Q2 		$11.6K Buy
563
+18
+3% +$369 ﹤0.01% 1748
2025
Q1 		$10.7K Buy
+545
New +$11.4K ﹤0.01% 1739
2024
Q4 		– Sell
-195
Closed -$4.75K – 4192
2024
Q3 		$4.75K Buy
195
+181
+1,293% +$4.84K ﹤0.01% 2012
2024
Q2 		$352 Sell
14
-171
-92% -$4.85K ﹤0.01% 2487
2024
Q1 		$5.53K Buy
185
+138
+294% +$4.05K ﹤0.01% 1890
2023
Q4 		$1.5K Sell
47
-103
-69% -$3.23K ﹤0.01% 2135
2023
Q3 		$5.29K Buy
+150
New +$5.72K ﹤0.01% 1792
2021
Q3 		– Sell
-108
Closed -$4K – 1869
2021
Q2 		$4K Hold
108
– – ﹤0.01% 1591
2021
Q1 		$4K Hold
108
– – ﹤0.01% 1485
2020
Q4 		$4K Buy
+108
New +$4.04K ﹤0.01% 1429

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Huntington National Bank's GMAB Position: Q2 2026 in Review

Huntington National Bank increased its Genmab (GMAB) stake by 10% in Q2 2026, buying an estimated $930 and bringing the position to 377 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Huntington National Bank first reported a position in GMAB in Q4 2020 and has held it in 14 quarters since. The position peaked at $18.9K in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Huntington National Bank held 377 shares of Genmab worth $10.4K as of Q2 2026.
  • Huntington National Bank bought 35 Genmab shares in Q2 2026, an estimated $930.
  • Genmab made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2011 holding.
  • Huntington National Bank first reported a position in Genmab in Q4 2020 and has held it in 14 quarters since.
  • Huntington National Bank's Genmab position peaked at $18.9K in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.